Showing results (91-100 of 183) with videos related to
Sort By:
Pageof 19
Cancer Research|October 16, 1999
Solid tissues removed from ATM homozygous deficient mice do not exhibit a mutator phenotype for second-step autosomal mutationsM S Turker, B M Gage, J A Rose, et al.Kidney International|August 1, 2000
Altered gene expression in kidneys of mice with 2,8-dihydroxyadenine nephrolithiasisL Wang, N Raikwar, L Deng, et al.Journal of Experimental Pathology|January 1, 1986
Differentiation alters the unstable expression of adenine phosphoribosyltransferase in mouse teratocarcinoma cellsM S Turker, J A Tischfield, P Rabinovitch, et al.Anticancer Research|September 1, 1992
Improved immunohistochemical detection of p53 protein in paraffin--embedded tissues reveals elevated levels in most head and neck and lung carcinomas: correlation with clinicopathological parametersZ P Pavelic, J L Gluckman, M Gapany, et al.Archives of Otolaryngology--Head & Neck Surgery|October 17, 1998
Alloantigen gene therapy for squamous cell carcinoma of the head and neck: results of a phase-1 trialL L Gleich, J L Gluckman, S Armstrong, et al.Anticancer Research|September 1, 1994
Overexpression of p53 protein is common in premalignant head and neck lesionsZ P Pavelic, Y Q Li, P J Stambrook, et al.[Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology|December 8, 2022
[Solitary fibrous tumor in choroid: a clinicopathologic analysis of two cases]H Sun, R R Cai, Y W BiDevelopmental Biology|July 9, 1999
The transcription factor MEF2C-null mouse exhibits complex vascular malformations and reduced cardiac expression of angiopoietin 1 and VEGFW Bi, C J Drake, J J SchwarzCancer Detection and Prevention|January 1, 1993
Relationship between immunohistochemically detectable p53 protein and prognostic factors in head and neck tumorsM Gapany, Z P Pavelic, S R Gapany, et al.Anticancer Research|September 1, 1994
The role of the p53 gene in the malignant transformation of pleomorphic adenomas of the parotid glandP D Righi, Y Q Li, M Deutsch, et al.Pageof 19